Solid-phase synthesis of linear and cyclic peptides containing a calix[4]arene amino acid

[1]  E. W. Meijer,et al.  Preparation and characterization of helical self-assembled nanofibers. , 2009, Chemical Society reviews.

[2]  S. Kubik.  Amino acid containing anion receptors. , 2009, Chemical Society reviews.

[3]  C. Massera,et al.  Self-Assembled Chiral Dimeric Capsules from Difunctionalized N,C-Linked Peptidocalix[4]arenes : Scope and Limitations , 2008 .

[4]  J. Garner,et al.  Design and synthesis of α-helical peptides and mimetics , 2007 .

[5]  J. Sherman,et al.  The design, synthesis, and characterization of the first cavitand-based de novo hetero-template-assembled synthetic proteins (Hetero-TASPs). , 2007, Organic & biomolecular chemistry.

[6]  J. Rothbard,et al.  Molecular Transporters: Synthesis of Oligoguanidinium Transporters and Their Application to Drug Delivery and Real‐Time Imaging , 2006, Chembiochem : a European journal of chemical biology.

[7]  F. Sansone,et al.  Peptido- and glycocalixarenes: playing with hydrogen bonds around hydrophobic cavities. , 2003, Accounts of chemical research.

[8]  D. Potenza,et al.  Potent integrin antagonists from a small library of RGD-including cyclic pseudopeptides. , 2001, Organic letters.

[9]  P. Cozzini,et al.  Synthesis and Properties ofUpper Rim C-Linked Peptidocalix[4]arenes , 2001 .

[10]  S. Sebti,et al.  Design of growth factor antagonists with antiangiogenic and antitumor properties , 2000, Oncogene.

[11]  M. Schwaiger,et al.  Carbohydrate Derivatives for Use in Drug Design: Cyclicαv-Selective RGD Peptides , 2000 .

[12]  Horst Kessler,et al.  N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists , 1999 .

[13]  F. Sansone,et al.  Synthesis and Structure of Chiral Cone Calix[4]arenes Functionalized at the Upper Rim with L-Alanine Units , 1998 .

[14]  R. Babine,et al.  MOLECULAR RECOGNITION OF PROTEIN-LIGAND COMPLEXES : APPLICATIONS TO DRUG DESIGN , 1997 .

[15]  Horst Kessler,et al.  Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer Therapy , 1997 .

[16]  G Tuchscherer,et al.  Templates in protein de novo design. , 1995, Journal of biotechnology.

[17]  J Engel,et al.  Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. , 1994, The Journal of biological chemistry.

[18]  J. Harrowfield,et al.  Calixarenes in the nanoworld , 2007 .